Mohammed Safi

461 total citations
31 papers, 278 citations indexed

About

Mohammed Safi is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mohammed Safi has authored 31 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mohammed Safi's work include Cancer Immunotherapy and Biomarkers (10 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Renal cell carcinoma treatment (3 papers). Mohammed Safi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Renal cell carcinoma treatment (3 papers). Mohammed Safi collaborates with scholars based in China, Yemen and United States. Mohammed Safi's co-authors include Mahmoud Al‐Azab, Mark Rowland, Toby Leslie, C. W. M. Whitty, Eveline Klinkenberg, Abdullah Shopit, Xiu Shan, Qiwei Chen, Jiwei Liu and Elina Idiiatullina and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Frontiers in Immunology.

In The Last Decade

Mohammed Safi

29 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammed Safi China 10 105 75 55 48 28 31 278
Luciano Mariani Italy 10 109 1.0× 108 1.4× 33 0.6× 35 0.7× 38 1.4× 15 350
Ahmet Hazini Germany 9 140 1.3× 83 1.1× 9 0.2× 23 0.5× 102 3.6× 14 299
Joshua J. Brotman United States 7 159 1.5× 101 1.3× 40 0.7× 39 0.8× 144 5.1× 7 389
Yingjie Ma China 12 51 0.5× 58 0.8× 30 0.5× 18 0.4× 25 0.9× 30 304
Periklis Katopodis United Kingdom 11 53 0.5× 85 1.1× 23 0.4× 27 0.6× 35 1.3× 22 277
Yao‐Chung Liu Taiwan 11 64 0.6× 73 1.0× 25 0.5× 22 0.5× 18 0.6× 32 288
Roman Zyla Canada 8 37 0.4× 72 1.0× 31 0.6× 54 1.1× 29 1.0× 15 280
Gwan Hee Han South Korea 12 67 0.6× 114 1.5× 24 0.4× 39 0.8× 33 1.2× 42 311

Countries citing papers authored by Mohammed Safi

Since Specialization
Citations

This map shows the geographic impact of Mohammed Safi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Safi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Safi more than expected).

Fields of papers citing papers by Mohammed Safi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammed Safi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Safi. The network helps show where Mohammed Safi may publish in the future.

Co-authorship network of co-authors of Mohammed Safi

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammed Safi. A scholar is included among the top collaborators of Mohammed Safi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammed Safi. Mohammed Safi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Safi, Mohammed, et al.. (2024). Aging-related biomarker discovery in the era of immune checkpoint inhibitors for cancer patients. Frontiers in Immunology. 15. 1348189–1348189. 14 indexed citations
3.
Safi, Mohammed, et al.. (2024). High RRM2 Correlates with Mitochondrial and Immune Responses in the Eosinophilic Subtype of Clear Cell Renal Cell Carcinoma. Journal of Inflammation Research. Volume 17. 8117–8133.
4.
Zhang, Zewen, et al.. (2023). A novel nomogram and prognostic factor for metastatic renal cell carcinoma survival in the era of immune checkpoint inhibitors (ICIs). Frontiers in Pharmacology. 13. 996404–996404. 2 indexed citations
5.
Safi, Mohammed, et al.. (2023). Interleukin-34 and immune checkpoint inhibitors: Unified weapons against cancer. Frontiers in Oncology. 13. 1099696–1099696. 5 indexed citations
6.
Al‐Azab, Mahmoud, Elina Idiiatullina, Mohammed Safi, & Kamal Hezam. (2023). Enhancers of mesenchymal stem cell stemness and therapeutic potency. Biomedicine & Pharmacotherapy. 162. 114356–114356. 16 indexed citations
7.
Safi, Mohammed, et al.. (2022). Immune Checkpoint Inhibitor (ICI) Genes and Aging in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical and Genomic Study. Cells. 11(22). 3641–3641. 10 indexed citations
8.
Safi, Mohammed, et al.. (2022). Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study. Therapeutic Advances in Urology. 14. 3623425969–3623425969. 8 indexed citations
9.
10.
Safi, Mohammed, et al.. (2022). Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines. Parkinson s Disease. 2022(1). 2700227–2700227. 17 indexed citations
11.
Tian, Yuan, et al.. (2022). Risk of Rash in PD-1 or PD-L1-Related Cancer Clinical Trials: A Systematic Review and Meta-Analysis. Journal of Oncology. 2022. 1–27. 5 indexed citations
12.
Wen, Shuang, Mohammed Safi, Honglong Wang, et al.. (2022). Molecular genetic and clinical characteristic analysis of primary signet ring cell carcinoma of urinary bladder identified by a novel OR2L5 mutation. Cancer Medicine. 12(4). 3931–3951. 4 indexed citations
13.
Safi, Mohammed, et al.. (2022). Surgery improves overall and cancer-specific survival of rare urinary cancers; population - based study. Surgical Oncology. 44. 101807–101807. 1 indexed citations
14.
Shopit, Abdullah, Shisheng Wang, Mohammed Safi, et al.. (2021). Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant pancreatic cancer cells. Phytomedicine. 91. 153711–153711. 5 indexed citations
15.
Safi, Mohammed, Mahmoud Al‐Azab, Dario Trapani, et al.. (2021). Age-Based Disparities in Metastatic Melanoma Patients Treated in the Immune Checkpoint Inhibitors (ICI) Versus Non-ICI Era: A Population-Based Study. Frontiers in Immunology. 12. 609728–609728. 12 indexed citations
16.
Safi, Mohammed, Mahmoud Al‐Azab, Yunlong Xia, et al.. (2020). PD-1/PDL-1 Inhibitors and Cardiotoxicity; Molecular, Etiological and Management Outlines. Journal of Advanced Research. 29. 45–54. 40 indexed citations
17.
18.
Safi, Mohammed, et al.. (2018). Risk interrelationship among multiple primary tumors. Medicine. 97(15). e0289–e0289. 2 indexed citations
19.
Sun, Xiuhua, et al.. (2017). Brain metastasis in a patient with melanoma receiving Pembrolizumab therapy. Medicine. 96(50). e9278–e9278. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luciano Mariani Breakdown of academic impact, for papers by Ahmet Hazini Breakdown of academic impact, for papers by Joshua J. Brotman Breakdown of academic impact, for papers by Yingjie Ma Breakdown of academic impact, for papers by Periklis Katopodis Breakdown of academic impact, for papers by Yao‐Chung Liu Breakdown of academic impact, for papers by Roman Zyla Breakdown of academic impact, for papers by Gwan Hee Han
Rankless by CCL
2026